Clinical Research, Pharma & Healthcare FinancingAvobis Bio Gets FDA Fast Track for AVB-114 Crohn’s TherapyPR NewswireFebruary 28, 2025March 3, 2025 by PR NewswireFebruary 28, 2025March 3, 2025096 Only implantable cell therapy for Crohn’s perianal fistulas with FDA IND clearance and Fast Track designation Avobis Bio LLC, a clinical stage company developing implantable...
